Sabadell Jordi, Salicrú Sabina, Montero-Armengol Anabel, Rodriguez-Mias Núria, Gil-Moreno Antonio, Poza Jose L
Urogynecology and Pelvic Floor Unit, Department of Obstetrics and Gynecology, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Passeig Vall d'Hebron 119-129, E-08035, Barcelona, Spain.
Int Urogynecol J. 2019 Oct;30(10):1719-1723. doi: 10.1007/s00192-018-3805-1. Epub 2018 Nov 15.
Stress urinary incontinence (SUI) may appear after the correction of pelvic organ prolapse (POP). The aim of this study was to externally validate a described predictive model for de novo SUI and to assess its clinical performance when used as a diagnostic test.
This was a retrospective descriptive study on a cohort of consecutive women treated in our institution. The main outcome used to validate the model was the presence of objective or subjective SUI 1 year after surgery. A receiver operating characteristic curve was generated from our population to evaluate the predictive accuracy and to compare it with the original model. A cutoff point of ≥50% was used to evaluate its clinical performance as a diagnostic test.
Of the full cohort, 169 women were suitable for analysis. The rate of de novo SUI was 11.8%. The predictive accuracy of the model in our population was similar to the original [area under the curve (AUC) = 0.69; 95% confidence interval (CI) = 0.58-0.80). However, its performance measures when evaluated as a diagnostic test were low: positive likelihood ratio = 2.71 and negative likelihood ratio = 0.86. Only 15 women presented a positive test result.
External validation of the model found a global predictive accuracy similar to that of the original model. Despite the study being underpowered to give firm conclusions, the test did not show a good clinical performance when applied to our population with low de novo SUI prevalence. A larger sample size is needed to validate the model conclusively.
压力性尿失禁(SUI)可能在盆腔器官脱垂(POP)矫正术后出现。本研究的目的是对外验证一种已描述的新发SUI预测模型,并评估其作为诊断试验时的临床性能。
这是一项对在我们机构接受治疗的连续女性队列进行的回顾性描述性研究。用于验证模型的主要结局是术后1年客观或主观SUI的存在情况。从我们的人群中生成受试者工作特征曲线,以评估预测准确性并与原始模型进行比较。使用≥50%的截断点来评估其作为诊断试验的临床性能。
在整个队列中,169名女性适合进行分析。新发SUI的发生率为11.8%。该模型在我们人群中的预测准确性与原始模型相似[曲线下面积(AUC)=0.69;95%置信区间(CI)=0.58 - 0.80]。然而,其作为诊断试验评估时的性能指标较低:阳性似然比=2.71,阴性似然比=0.86。只有15名女性检测结果为阳性。
对该模型的外部验证发现总体预测准确性与原始模型相似。尽管该研究样本量不足,无法得出确凿结论,但该试验应用于我们新发SUI患病率较低的人群时,并未显示出良好的临床性能。需要更大的样本量来最终验证该模型。